Literature DB >> 10657377

Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography.

M N Nanjee1, E A Brinton.   

Abstract

BACKGROUND: Very small apolipoprotein (apo) A-I-containing lipoprotein (Sm LpA-I) particles with pre-beta electrophoretic mobility may play key roles as "nascent" and/or "senescent" HDL; however, methods for their isolation are difficult and often semiquantitative.
METHODS: We developed a preparative method for separating Sm LpA-I particles from human plasma by high-performance size-exclusion chromatography (HP-SEC), using two gel permeation columns (Superdex 200 and Superdex 75) in series and measuring apo A-I content in column fractions in 30 subjects with HDL-cholesterol (HDL-C) concentrations of 0.4-3.83 mmol/L.
RESULTS: Three major sizes of apo A-I-containing particles were detected: an approximately 15-nm diameter ( approximately 700 kDa) species; a 7. 5-12 nm (100-450 kDa) species; and a 5.8-6.3 nm species (40-60 kDa, Sm LpA-I particles), containing 0.2-3%, 80-96%, and 2-15% of plasma total apo A-I, respectively. Two subjects with severe HDL deficiency had increased relative apo A-I content in Sm LpA-I: 25% and 37%, respectively. The percentage of apo A-I in Sm LpA-I correlated positively with fasting plasma triglyceride concentrations (r = 0. 581; P <0.0005) and inversely with total apo A-I (r = -0.551; P <0. 0013) and HDL-C concentrations (r = -0.532; P <0.0017), although the latter two relationships were largely attributable to extremely hypoalphalipoproteinemic subjects. The percentage of apo A-I in Sm LpA-I correlated with that in pre-beta-migrating species by crossed immunoelectrophoresis (r = 0.98; P <0.0001; n = 24) and with that in the d >1.21 kg/L fraction by ultracentrifugation (r = 0.86; P <0. 001; n = 20). Sm LpA-I particles, on average, appear to contain two apo A-I and four phospholipid molecules but little or no apo A-II, triglyceride, or cholesterol.
CONCLUSIONS: We present a new HP-SEC method for size separation of native HDL particles from plasma, including Sm Lp A-I, which may play important roles in the metabolism of HDL and in its contribution(s) to protection against atherosclerosis. This method provides a basis for further studies of the structure and function of Sm Lp A-I.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657377

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Impact of self-association on function of apolipoprotein A-I.

Authors:  Shobini Jayaraman; Sumiko Abe-Dohmae; Shinji Yokoyama; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

2.  Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.

Authors:  George V Z Dedoussis; Sandy Maumus; John Skoumas; Despoina M Choumerianou; Christos Pitsavos; Christodoulos Stefanadis; Sophie Visvikis-Siest
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

3.  Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.

Authors:  Andrzej Witkowski; Gary K L Chan; Jennifer C Boatz; Nancy J Li; Ayuka P Inoue; Jaclyn C Wong; Patrick C A van der Wel; Giorgio Cavigiolio
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

4.  Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry.

Authors:  Lisamarie A Collins; Shama P Mirza; Ahmed H Kissebah; Michael Olivier
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

5.  Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid.

Authors:  Norman E Miller; Waldemar L Olszewski; Hiroaki Hattori; Irina P Miller; Takeshi Kujiraoka; Tomoichiro Oka; Tadao Iwasaki; M Nazeem Nanjee
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-11       Impact factor: 4.310

6.  Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: relevance to high-density lipoprotein biogenesis.

Authors:  Shobini Jayaraman; Giorgio Cavigiolio; Olga Gursky
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

7.  High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol.

Authors:  Amar A Sethi; Maureen Sampson; Russell Warnick; Nehemias Muniz; Boris Vaisman; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Alan T Remaley
Journal:  Clin Chem       Date:  2010-05-28       Impact factor: 8.327

8.  Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.

Authors:  Osamu Miyazaki; Jun Ogihara; Isamu Fukamachi; Takafumi Kasumi
Journal:  J Lipid Res       Date:  2013-12-04       Impact factor: 5.922

9.  FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice.

Authors:  Yoshinari Uehara; Setsuko Ando; Eiji Yahiro; Kosuke Oniki; Makoto Ayaori; Satomi Abe; Emi Kawachi; Bo Zhang; Seijiro Shioi; Hiroyuki Tanigawa; Satoshi Imaizumi; Shin-Ichiro Miura; Keijiro Saku
Journal:  J Am Heart Assoc       Date:  2013-05-24       Impact factor: 5.501

10.  Analysis of "On/Off" Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics.

Authors:  J Lu; Y Cleary; C Maugeais; C I Kiu Weber; N A Mazer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.